By Rachel Graf ( November 29, 2017, 2:37 PM EST) -- Johnson & Johnson and its subsidiary Janssen Biotech Inc. urged a Pennsylvania federal court Tuesday to toss a suit brought by Pfizer Inc. alleging the companies used anti-competitive tactics to maintain the dominance of their biologic Remicade, saying Pfizer hasn't demonstrated the prices of its own biosimilar are competitive....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.